Publications of Yvonne Genzel

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (6^th Edition): Exercise on COVID-19 vaccines immunology and protection. ESACT Course 2021, Virtual Meeting (2021)

Genzel, Y.: Process intensification for virus production: stirred or shaken perfusion leads to very high titres. World Vaccine Congress Washington, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition):Cells, Upstream Processing and Process Intensification. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Overview on COVID-19 candidate vaccines. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Exercise on COVID-19 antigen design options and vaccination platforms. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Exercise on COVID-19 vaccine manufacturing platforms and cost-effectiveness. ESACT Course 2020, Virtual Meeting (2020)

Genzel, Y.: ESACT Course on Cell Culture-based Viral Vaccines (5^th Edition): Exercise on COVID-19 vaccines immunology and protection. ESACT Course 2020, Virtual Meeting (2020)

Pelz, L.; Rüdiger, D.; Alnaji, F. G.; Genzel, Y.; Brooke, C. B.; Kupke, S. Y.; Reichl, U.: Evolution and selection of influenza a virus defective interfering particles in a semi-continuous production system for the use as antiviral. The seventh ESWI Influenza Conference, Virtual Meeting (2020)

Reichl, U.; Vazquez-Ramirez, D.; Tapia, F.; Nikolay, A.; Genzel, Y.: Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Plenarsitzung der Sächischen Akademie der Wissenschaften zu Leipzig, Leipzig, Germany (2020)

Genzel, Y.: Next-generation production platforms for viral therapies. Simposio Max Planck / Fronteras de la Ciencia Bogotá, Bogota, Colombia (2019)

Genzel, Y.: Upstream Process Development - From Master Seed to Production. ESACT Cell culture based viral vaccine course, Llafranc, Spanien (2019)

Genzel, Y.: Upstream Process Intensification. ESACT Cell culture based viral vaccine course, Llafranc, Spanien (2019)

Genzel, Y.: Orbital Shaken Bioreactors: Perfusion with shaken bioreactors. Kühner Workshop Meeting, San Martin, Spain (2019)

Laske, T.; Tapia, F.; Wasik, M.; Rammhold, M.; Genzel, Y.; Reichl, U.: Production of defective interfering particles of influenza A virus in continuously cultured bioreactors at two residence times - insights from within-host virus dynamics. 4th Workshop on Viral Dynamics, Paris, France (2019)

Marichal-Gallardo, P.; Genzel, Y.; Börner, K.; Grimm, D.; Wolff, M.W.; Reichl, U.: A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. ECI Advancing Manufacture of Cell and Gene Therapies VI, Coronado, United States of America (2019)